title: Prognostic value of breast cancer aromatase.
abstract: The estrogen receptor, progesterone receptor, and intratumoral aromatase content of 127 breast carcinomas were determined. Patients whose tumor contained either estrogen or progesterone receptors had a longer disease-free interval, but no difference in survival was observed. Measurable aromatase activity was detected in 78 of 113 (69%) tumors. There was no relationship between aromatase activity and disease-free interval or survival.
authors.affiliation: Department of Medicine, Milton S. Hershey Medical Center, Hershey, Pennsylvania 17033.
authors.forename: A
authors.initials: A
authors.lastname: Lipton
authors.forename: R J
authors.initials: RJ
authors.lastname: Santen
authors.forename: S J
authors.initials: SJ
authors.lastname: Santner
authors.forename: H A
authors.initials: HA
authors.lastname: Harvey
authors.forename: S I
authors.initials: SI
authors.lastname: Sanders
authors.forename: Y L
authors.initials: YL
authors.lastname: Matthews
mesh_terms: D001141:Aromatase / Q000378:metabolism*; D001943:Breast Neoplasms / Q000737:chemistry / Q000201:enzymology* / Q000401:mortality*; D006801:Humans; D011379:Prognosis; D011960:Receptors, Estrogen / Q000032:analysis; D011980:Receptors, Progesterone / Q000032:analysis; D012008:Recurrence; D016019:Survival Analysis
chemical_list: D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; D001141:Aromatase